{"transactions":[{"id":730879,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T22:20:49.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":222684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted on June 17, 2026 (the \"Grant Date\"). The RSUs vest in full on the earlier to occur of (i) the one (1) year anniversary of the Grant Date and (ii) the date of the 2027 annual meeting of the Company's stockholders, subject to continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted on June 17, 2026 (the \"Grant Date\"). The RSUs vest in full on the earlier to occur of (i) the one (1) year anniversary of the Grant Date and (ii) the date of the 2027 annual meeting of the Company's stockholders, subject to continued service through the applicable vesting date."}],"balance_after":258705,"source":{"system":"sec-edgar","filing":"0001104659-26-076513","document":"tm2618486-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000110465926076513/tm2618486-4_4seq1.xml","form_type":"4"}},{"id":732538,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:10:10.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":37037,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 17, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":78076,"source":{"system":"sec-edgar","filing":"0001193125-26-275851","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526275851/ownership.xml","form_type":"4"}},{"id":1123363,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T01:35:06.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10752,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":41039,"source":{"system":"sec-edgar","filing":"0000950170-25-081957","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025081957/ownership.xml","form_type":"4"}},{"id":1135750,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-23T20:51:31.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":308641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") will be settled in cash based on the fair market value of the Issuer's Class A Common Stock on the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the RSUs shall vest in full on the one year anniversary of May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the RSUs shall vest in full on the one year anniversary of May 21, 2025."}],"balance_after":308641,"derivative":{"underlying":"Class A Common Stock","underlying_shares":308641},"source":{"system":"sec-edgar","filing":"0001610717-25-000132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000161071725000132/form4.xml","form_type":"4"}},{"id":1411055,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-11T01:04:24.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":36021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units granted on August 31, 2024 (the \"Grant Date\"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":36021,"source":{"system":"sec-edgar","filing":"0001104659-24-098707","document":"tm2423757-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000110465924098707/tm2423757-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-09-04"}},{"id":1416263,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-09-05T01:49:34.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":96210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of stock options granted on August 31, 2024 (the \"Grant Date\"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of stock options granted on August 31, 2024 (the \"Grant Date\"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":96210,"derivative":{"exercise_price":0.83,"expiration_date":"2034-08-30","underlying":"Class A Common Stock","underlying_shares":96210},"source":{"system":"sec-edgar","filing":"0001104659-24-097059","document":"tm2423415-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000110465924097059/tm2423415-6_4seq1.xml","form_type":"4"}},{"id":1416262,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-05T01:49:34.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":36021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units granted on August 31, 2024 (the \"Grant Date\"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":36021,"source":{"system":"sec-edgar","filing":"0001104659-24-097059","document":"tm2423415-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000110465924097059/tm2423415-6_4seq1.xml","form_type":"4"}},{"id":1485371,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:23:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":2554,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":30287,"source":{"system":"sec-edgar","filing":"0000950170-24-071320","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024071320/ownership.xml","form_type":"4"}},{"id":1565034,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2024-03-21T23:51:04.000Z","date":"2024-03-19","kind":"grant","planned":false,"acquired":true,"shares":16260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of stock options granted on March 19, 2024 (the \"Grant Date\"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Each option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of stock options granted on March 19, 2024 (the \"Grant Date\"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Each option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company."}],"balance_after":16260,"derivative":{"exercise_price":14.4,"expiration_date":"2034-03-18","underlying":"Common Stock","underlying_shares":16260},"source":{"system":"sec-edgar","filing":"0001104659-24-037439","document":"tm249503-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000110465924037439/tm249503-6_4seq1.xml","form_type":"4"}},{"id":1806150,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2023-08-16T20:06:36.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":58851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":58851,"derivative":{"exercise_price":5.47,"expiration_date":"2033-08-13","underlying":"Common Stock","underlying_shares":58851},"source":{"system":"sec-edgar","filing":"0001104659-23-092548","document":"tm2323956-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000110465923092548/tm2323956-3_4seq1.xml","form_type":"4"}},{"id":1822966,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":77453,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"At the Effective Time, each outstanding award of restricted stock unit (\"RSU\") representing the contingent right to receive shares of AEON common stock (each an \"AEON RSU\") was automatically cancelled and converted into an RSU representing the contingent right to receive a number of shares of common stock of the Issuer equal to (i) the number of shares of AEON common stock subject to the applicable AEON RSU multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"shares","element":"transactionShares","label":"F14","text":"At the Effective Time, each outstanding award of restricted stock unit (\"RSU\") representing the contingent right to receive shares of AEON common stock (each an \"AEON RSU\") was automatically cancelled and converted into an RSU representing the contingent right to receive a number of shares of common stock of the Issuer equal to (i) the number of shares of AEON common stock subject to the applicable AEON RSU multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share."},{"field":"shares","element":"transactionShares","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":77453,"derivative":{"underlying":"Stock Options","underlying_shares":77453},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822965,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":7765,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F13","text":"Represents an award of stock options granted on March 9, 2022, which vests in three yearly installments from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents an award of stock options granted on March 9, 2022, which vests in three yearly installments from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":7765,"derivative":{"underlying":"Stock Options","underlying_shares":7765},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822964,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":21198,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":21198,"derivative":{"underlying":"Stock Options","underlying_shares":21198},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822963,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":19800,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents an award of stock options granted on March 5, 2021, which vested ratably over one year from March 5, 2021. Such options expire on March 5, 2031. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents an award of stock options granted on March 5, 2021, which vested ratably over one year from March 5, 2021. Such options expire on March 5, 2031. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":19800,"derivative":{"underlying":"Stock Options","underlying_shares":19800},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822962,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":21974,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F10","text":"Represents an award of stock options granted on August 5, 2020, which vested ratably over one year from March 4, 2020. Such options expire on August 1, 2030. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents an award of stock options granted on August 5, 2020, which vested ratably over one year from March 4, 2020. Such options expire on August 1, 2030. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":21974,"derivative":{"underlying":"Stock Options","underlying_shares":21974},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822961,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":38824,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":38824,"derivative":{"underlying":"Stock Options","underlying_shares":38824},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822960,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":38824,"ownership":{"direct":false,"nature":"Held by Oleg Grodnensky"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":38824,"derivative":{"underlying":"Stock Options","underlying_shares":38824},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822959,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Private Placement Warrants","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":false,"shares":5280000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5280000},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822958,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":false,"shares":6900000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"shares","element":"transactionShares","label":"F7","text":"The reporting person disposed of all Class B common stock upon the consummation of the Issuer's Initial Business Combination, which were automatically exchanged on a one-for-one basis into Class A common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The Sponsor is the record holder of the securities reported herein. Messrs Grodnensky, Palmisano, and Malik are the managers of the Sponsor and share voting and investment discretion with respect to the securities held of record by the Sponsor."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6900000},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822957,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":89163,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"These securities, which were acquired upon the closing of the Initial Business Combination pursuant to the terms of the BCA as a result of the cancellation of the shares of Old AEON (\"Old AEON Common Stock\") held by Mr. Malik and Sabina Taneja and the automatic conversion of such shares into 2.328 (the \"Exchange Ratio\") shares of Class A common stock of the Issuer, are held directly by Mr. Malik, a manager of the Sponsor, and Ms. Taneja. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":6989163,"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822956,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":6900000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"}],"balance_after":6900000,"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1867705,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:35:07.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":27733,"source":{"system":"sec-edgar","filing":"0001209191-23-034333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123034333/doc4.xml","form_type":"4"}},{"id":2245525,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-04T00:23:46.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":8624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant.  \"Date of Grant\" shall mean June 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":22002,"source":{"system":"sec-edgar","filing":"0001209191-22-034395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122034395/doc4.xml","form_type":"4"}},{"id":2613317,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:18:01.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":7645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of August 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":13378,"source":{"system":"sec-edgar","filing":"0000899243-21-031811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031811/doc4.xml","form_type":"4"}},{"id":2613316,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:18:01.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":5733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the date immediately prior to the first annual meeting of stockholders following August 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":5733,"source":{"system":"sec-edgar","filing":"0000899243-21-031811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031811/doc4.xml","form_type":"4"}},{"id":2981663,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":483849,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":15.55,"expiration_date":"2021-09-17","underlying":"Ordinary Shares","underlying_shares":483849},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981662,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":4112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":17.7,"expiration_date":"2022-04-16","underlying":"Ordinary Shares","underlying_shares":4112},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981661,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":145500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":20.75,"expiration_date":"2022-05-09","underlying":"Ordinary Shares","underlying_shares":145500},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981660,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":9771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":22.55,"expiration_date":"2023-04-17","underlying":"Ordinary Shares","underlying_shares":9771},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981659,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":144625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":23.93,"expiration_date":"2023-05-14","underlying":"Ordinary Shares","underlying_shares":144625},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981658,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":7939,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":30.14,"expiration_date":"2024-04-01","underlying":"Ordinary Shares","underlying_shares":7939},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981657,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":129462,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":29.06,"expiration_date":"2024-05-13","underlying":"Ordinary Shares","underlying_shares":129462},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981656,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":239481,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":20.62,"expiration_date":"2025-10-13","underlying":"Ordinary Shares","underlying_shares":239481},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981655,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":598702,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":20.62,"expiration_date":"2025-10-13","underlying":"Ordinary Shares","underlying_shares":598702},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981654,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":271076,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":21.42,"expiration_date":"2026-07-19","underlying":"Ordinary Shares","underlying_shares":271076},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981653,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":137373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":137373},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981652,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":149008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":149008},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981651,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":181429,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":181429},"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981650,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":229054,"price":30.75,"value":7043410.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981649,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":229054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":229054,"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981648,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":95975,"price":30.75,"value":2951231.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"See Exhibit 99.1"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981647,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":148387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration.  See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 83,646 Shares issuable upon vesting of the Wright RSUs and 12,329 Shares issuable upon vesting of the 2020 RSUs.  See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":95975,"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":2981646,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T19:45:52.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":863885,"price":30.75,"value":26564463.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2019, Wright Medical Group N.V. (the \"Issuer\") entered into a purchase agreement (the \"Purchase Agreement\") with Stryker Corporation and its subsidiary, Stryker B.V. (the \"Purchaser\").  Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (\"Shares\"), of the Issuer (the \"Offer\"), and, on November 11, 2020 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 863,885 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 83,646 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, \"Wright RSUs\") and 160,716 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the \"2020 RSUs\").  See notes (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":244362,"source":{"system":"sec-edgar","filing":"0001235802-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000123/primary_doc.xml","form_type":"4"}},{"id":3075689,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Chief Executive"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-27T20:01:15.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":160716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.  The grant agreement contemplates that the shares will vest pro rata through the closing of the previously announced Stryker transaction, and shares unvested at closing will be cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,919 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 219,707 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":1108247,"source":{"system":"sec-edgar","filing":"0001235802-20-000081","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000081/primary_doc.xml","form_type":"4"}},{"id":3095462,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-01T20:16:02.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":93066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the payout of a performance share unit award for the June 26, 2017 - June 28, 2020 performance period under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, as approved by the Issuer's Compensation Committee of its Board of Directors.  Performance share unit awards are paid in ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,919 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 58,991 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":947531,"source":{"system":"sec-edgar","filing":"0001235802-20-000066","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000066/primary_doc.xml","form_type":"4"}},{"id":3209220,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-03-16T20:04:18.000Z","date":"2020-03-13","kind":"gift","acquired":false,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 23,584 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 64,919 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 58,991 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":854465,"source":{"system":"sec-edgar","filing":"0001235802-20-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000021/primary_doc.xml","form_type":"4"}},{"id":3209219,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-03-16T20:04:18.000Z","date":"2020-03-09","kind":"gift","acquired":false,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 23,584 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 64,919 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 58,991 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":871065,"source":{"system":"sec-edgar","filing":"0001235802-20-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580220000021/primary_doc.xml","form_type":"4"}},{"id":3357816,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-27T21:27:16.000Z","date":"2019-11-26","kind":"exercise","acquired":false,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of a vested stock option in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option has fully vested."}],"balance_after":483849,"derivative":{"exercise_price":15.55,"expiration_date":"2021-09-17","underlying":"Ordinary Shares","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001235802-19-000138","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580219000138/primary_doc.xml","form_type":"4"}},{"id":3357815,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-27T21:27:16.000Z","date":"2019-11-26","kind":"exercise","acquired":true,"shares":145000,"price":15.55,"value":2254750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of a vested stock option in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,584 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 64,919 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 58,991 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":887665,"source":{"system":"sec-edgar","filing":"0001235802-19-000138","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580219000138/primary_doc.xml","form_type":"4"}},{"id":3360143,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-11-25T21:32:24.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":3005,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"At the Effective Time, each outstanding restricted stock unit (\"Issuer RSU\") (excluding any Issuer RSU that vested prior to or as a result of the consummation of the Merger and which settled in shares of Issuer Common Stock that were converted into the right to receive shares of Parent Common Stock as a result of the Merger) was assumed by Parent and converted into the right to receive shares of Parent Common Stock (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such Issuer RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"At the Effective Time, each outstanding restricted stock unit (\"Issuer RSU\") (excluding any Issuer RSU that vested prior to or as a result of the consummation of the Merger and which settled in shares of Issuer Common Stock that were converted into the right to receive shares of Parent Common Stock as a result of the Merger) was assumed by Parent and converted into the right to receive shares of Parent Common Stock (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such Issuer RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"At the Effective Time, each outstanding restricted stock unit (\"Issuer RSU\") (excluding any Issuer RSU that vested prior to or as a result of the consummation of the Merger and which settled in shares of Issuer Common Stock that were converted into the right to receive shares of Parent Common Stock as a result of the Merger) was assumed by Parent and converted into the right to receive shares of Parent Common Stock (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such Issuer RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001209191-19-057939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119057939/doc4.xml","form_type":"4"}},{"id":3360142,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-25T21:32:24.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":10224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."}],"balance_after":0,"derivative":{"exercise_price":3.69,"expiration_date":"2028-07-17","underlying":"Common Stock","underlying_shares":10224},"source":{"system":"sec-edgar","filing":"0001209191-19-057939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119057939/doc4.xml","form_type":"4"}},{"id":3360141,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-25T21:32:24.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":12628,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."}],"balance_after":0,"derivative":{"exercise_price":2.67,"expiration_date":"2027-06-26","underlying":"Common Stock","underlying_shares":12628},"source":{"system":"sec-edgar","filing":"0001209191-19-057939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119057939/doc4.xml","form_type":"4"}},{"id":3360140,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-25T21:32:24.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":28089,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.34,"expiration_date":"2028-09-13","underlying":"Common Stock","underlying_shares":28089},"source":{"system":"sec-edgar","filing":"0001209191-19-057939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119057939/doc4.xml","form_type":"4"}},{"id":3360139,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-25T21:32:24.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":1081,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."}],"balance_after":0,"derivative":{"exercise_price":70.8,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":1081},"source":{"system":"sec-edgar","filing":"0001209191-19-057939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119057939/doc4.xml","form_type":"4"}},{"id":3360138,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-25T21:32:24.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":8314,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":0,"derivative":{"exercise_price":12.73,"expiration_date":"2029-01-08","underlying":"Common Stock","underlying_shares":8314},"source":{"system":"sec-edgar","filing":"0001209191-19-057939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119057939/doc4.xml","form_type":"4"}},{"id":3360137,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-25T21:32:24.000Z","date":"2019-11-21","kind":"disposition_to_issuer","acquired":false,"shares":37733,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of August 7, 2019, by and among Avedro, Inc. (the \"Issuer\"), Glaukos Corporation (\"Parent\") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), on November 21, 2019, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each share of common stock of the Issuer (\"Issuer Common Stock\") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock (\"Parent Common Stock\").  The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-057939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119057939/doc4.xml","form_type":"4"}},{"id":3441320,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-08-12T20:05:20.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":46654,"price":21.386,"value":997742.444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $21.07 to $21.72, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,584 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 90,436 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 58,991 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":742665,"source":{"system":"sec-edgar","filing":"0001235802-19-000099","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580219000099/primary_doc.xml","form_type":"4"}},{"id":3453365,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T22:12:47.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":181429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 26, 2020 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":181429,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":181429},"source":{"system":"sec-edgar","filing":"0001235802-19-000091","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580219000091/primary_doc.xml","form_type":"4"}},{"id":3453364,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-07-30T22:12:47.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":58991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,584 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 90,436 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 58,991 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":696011,"source":{"system":"sec-edgar","filing":"0001235802-19-000091","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580219000091/primary_doc.xml","form_type":"4"}},{"id":3486499,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-18T23:51:41.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on June 1, 2020, subject to Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on June 1, 2020, subject to Reporting Person's continuous service through such date."}],"balance_after":3005,"derivative":{"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001209191-19-037847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119037847/doc4.xml","form_type":"4"}},{"id":3650353,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-20T00:15:31.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":8314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (x) June 1, 2020 and (y) the first anniversary of the first annual meeting of the Issuer's stockholders following the Issuer's initial public offering, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":8314,"derivative":{"exercise_price":12.73,"expiration_date":"2029-01-08","underlying":"Common Stock","underlying_shares":8314},"source":{"system":"sec-edgar","filing":"0001209191-19-011337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119011337/doc4.xml","form_type":"4"}},{"id":3650352,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series CC Convertible Preferred Stock","published_at":"2019-02-20T00:15:31.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":21414,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21414},"source":{"system":"sec-edgar","filing":"0001209191-19-011337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119011337/doc4.xml","form_type":"4"}},{"id":3650351,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series BB Convertible Preferred Stock","published_at":"2019-02-20T00:15:31.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":1310,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1310},"source":{"system":"sec-edgar","filing":"0001209191-19-011337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119011337/doc4.xml","form_type":"4"}},{"id":3650350,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series AA Convertible Preferred Stock","published_at":"2019-02-20T00:15:31.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":9322,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9322},"source":{"system":"sec-edgar","filing":"0001209191-19-011337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119011337/doc4.xml","form_type":"4"}},{"id":3650349,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-20T00:15:31.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":21414,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":37733,"source":{"system":"sec-edgar","filing":"0001209191-19-011337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119011337/doc4.xml","form_type":"4"}},{"id":3650348,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-20T00:15:31.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":1310,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":16319,"source":{"system":"sec-edgar","filing":"0001209191-19-011337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119011337/doc4.xml","form_type":"4"}},{"id":3650347,"issuer":{"id":153528,"kind":"organization","name":"AVEDRO INC","symbol":"AVDR"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-20T00:15:31.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":9322,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series AA Convertible Preferred Stock, Series BB Convertible Preferred Stock and Series CC Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are directly owned by the Robert J. Palmisano 2010 Trust (the \"Trust\"). The Reporting Person is the trustee of the Trust."}],"balance_after":15009,"source":{"system":"sec-edgar","filing":"0001209191-19-011337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000120919119011337/doc4.xml","form_type":"4"}},{"id":3861011,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T20:16:34.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":149008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":149008,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":149008},"source":{"system":"sec-edgar","filing":"0001235802-18-000102","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580218000102/primary_doc.xml","form_type":"4"}},{"id":3861010,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-07-26T20:16:34.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":55536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 119,584 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 102,069 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":637020,"source":{"system":"sec-edgar","filing":"0001235802-18-000102","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580218000102/primary_doc.xml","form_type":"4"}},{"id":4251235,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T23:17:47.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":137373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":137373,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":137373},"source":{"system":"sec-edgar","filing":"0001235802-17-000137","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580217000137/primary_doc.xml","form_type":"4"}},{"id":4251234,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":1,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2017-07-26T23:17:47.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":46533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 215,583 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 46,533 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":581484,"source":{"system":"sec-edgar","filing":"0001235802-17-000137","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000123580217000137/primary_doc.xml","form_type":"4"}}]}